In addition, the expression of these two genes was decreased in myxoma tissues from patients with variations of neither KIF1C nor PRKAR1A. This result suggests that there may be other pathogenic genes for CM and that the crosstalk between KIF1C and PRKAR1A is the core pathogenic event. The gene discussed is PRKAR1A; the disease is myxoma.